Rhythm Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity.

CEO

David P. Meeker

CEODavid P. Meeker

Employees

140

Employees140

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2008

Founded2008

Employees

140

Employees140

RYTM Key Statistics

Market cap

1.41B

Market cap1.41B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

467.78K

Average volume467.78K

High today

—

High today—

Low today

—

Low today—

Open price

$24.70

Open price$24.70

Volume

0.00

Volume0.00

52 Week high

$30.98

52 Week high$30.98

52 Week low

$3.04

52 Week low$3.04

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

RYTM Earnings

-$1.05

-$0.70

-$0.35

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 1, Pre-Market

ActualExpected Mar 1, Pre-Market